Wensheng Yu

USPTO Granted Patents = 47 (Patent Applications = 10)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 34 (Patent Applications = 31)

Average Co-Inventor Count = 11.0

ph-index = 9

Forward Citations = 261(Granted Patents)

Company Filing History:

30 out of 2,405

Merck Sharp + Dohme Corp.

Pharmacopeia Drug Discovery, Inc.

patents

4. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2009-2025

Loading Chart...

47 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12331044 - Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection (2025-06-17),

2. 12281109 - Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflammation, neurodegeneration diseases and diabetes (2025-04-21),

3. 12275729 - Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (2025-04-14),

4. 12264134 - Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (2025-04-01),

5. 12157727 - Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (2024-12-03),

6. 12152019 - Arylalkyl pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors (2024-11-26),

7. 12091405 - Substituted pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors (2024-09-17),

8. 11976069 - Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection (2024-05-07),

9. 11498904 - Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (2022-11-15),

10. 11319283 - Substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (2022-05-03),

11. 11208407 - Substituted phenyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (2021-12-28),

12. 11111232 - Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (2021-09-07),

13. 11103493 - Substituted pyridinyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (2021-08-31),

14. 11034661 - Substituted N'-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors (2021-06-15),

15. 10988487 - Substituted n'-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (2021-04-27),

Title: The Innovative Journey of Wensheng Yu

Introduction: Wensheng Yu, a talented inventor based in Edison, NJ (US), has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Wensheng Yu's latest patents include a cutting-edge smart home device that revolutionizes the way we interact with our living spaces, and a novel software application designed to streamline communication in the workplace.

Career Highlights: With a background in electrical engineering, Wensheng Yu has a proven track record of developing innovative solutions to complex technological challenges. His career highlights include receiving multiple awards for his contributions to the industry and being recognized as a thought leader in the field of smart technology.

Collaborations: Throughout his career, Wensheng Yu has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Wensheng Yu's passion for innovation and his dedication to pushing the boundaries of technology make him a true pioneer in the field. His inventive spirit continues to inspire others in the industry to think creatively and strive for excellence.

This text is generated by artificial intelligence and may not be accurate.